![](/img/cover-not-exists.png)
A Risk-Benefit Assessment of Drugs Used in the Eradication ofHelicobacter pyloriInfection
Dr Andreas Hackelsberger,Peter MalfertheinerVolume:
15
Language:
english
Journal:
Drug Safety
DOI:
10.2165/00002018-199615010-00003
Date:
July, 1996
File:
PDF, 4.19 MB
english, 1996